Genomed SA banner
G

Genomed SA
WSE:GEN

Watchlist Manager
Genomed SA
WSE:GEN
Watchlist
Price: 25.8 PLN 4.88% Market Closed
Market Cap: zł34.1m

Intrinsic Value

The intrinsic value of one GEN stock under the Base Case scenario is hidden PLN. Compared to the current market price of 25.8 PLN, Genomed SA is hidden .

GEN Intrinsic Value
LOCKED
Unlock
Get notified when the price drop
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Intrinsic Value Locked
Margin of Safety 20% Locked
Current Price zł25.8
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Intrinsic Value History
Dive into the past to invest in the future

GEN looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if GEN is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about GEN?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is GEN valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Genomed SA.

Explain Valuation
Alternatives to GEN

Wall St
Price Targets

Dividends

Shareholder Yield
Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one GEN stock?

The intrinsic value of one GEN stock under the Base Case scenario is hidden PLN.

Is GEN stock undervalued or overvalued?

Compared to the current market price of 25.8 PLN, Genomed SA is hidden .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett